Observational studyJournal of atherosclerosis and thrombosis2026

Enhancement of ABCA1 and ABCG1 Expression and Cholesterol Efflux by a Metabolite of Tipelukast: A Potential Therapeutic Strategy for Atherosclerosis.

Huicheng Qi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.